Winchester, MA, United States of America

Gregory N Stephanopoulos

USPTO Granted Patents = 54 (Patent Applications = 16)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 13

Forward Citations = 723(Granted Patents)

Forward Citations (Not Self Cited) = 643(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Pasadena, CA (US) (1989)
Cambridge, MA (US) (2021)
Winchester, MA (US) (1990 - 2024)

Company Filing History:

48 out of 8,369

Massachusetts Institute of Technology

patents

11 out of 805

National University of Singapore

Children's Medical Center Corporation

patents

5. 2 out of 4,547

California Institute of Technology

patents

6. 1 out of 6

President and Fellows of Havard College

Whitehead Institute for Biomedical Research

patents

10. 1 out of 2,882

The General Hospital Corporation

patents

11. 1 out of 1,991

The State University of New York

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

54 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11891646 - Bioprocess and microbe engineering for total carbon utilization in biofuel production (2024-02-06),

2. 11649472 - Controlling metabolism by substrate cofeeding (2023-05-16),

3. 11566265 - Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway (2023-01-31),

4. 11180764 - Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components (2021-11-23),

5. 11142770 - Isolated oleaginous yeast (2021-10-12),

6. 11041161 - Metabolic flux biosensor (2021-06-22),

7. 11034980 - Microbial engineering for the production of isoprenoids (2021-06-15),

8. 11028413 - Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway (2021-06-08),

9. 10676721 - Bacteriophages expressing antimicrobial peptides and uses thereof (2020-06-09),

10. 10633675 - Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway (2020-04-28),

11. 10519470 - Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway (2019-12-31),

12. 10294481 - Microbial production of renewable glycolate (2019-05-21),

13. 10227597 - Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway (2019-03-12),

14. 10174347 - Method for producing lactic acid from organic waste (2019-01-08),

15. 10064885 - Metabolic gene, enzyme, and flux targets for cancer therapy (2018-09-04),

Title: The Innovative Journey of Gregory N Stephanopoulos

Introduction: Gregory N Stephanopoulos, a distinguished inventor hailing from Winchester, MA, has made significant contributions to the field of innovations and patents.

Latest Patents: Gregory N Stephanopoulos holds several patents in the areas of biotechnology and chemical engineering, focusing on sustainable solutions for various industries.

Career Highlights: With a career spanning several decades, Gregory N Stephanopoulos has been a trailblazer in the development of novel processes and technologies. His work has revolutionized the way we approach challenges in bioprocessing and bioengineering.

Collaborations: Throughout his career, Gregory N Stephanopoulos has collaborated with leading researchers, scientists, and industry experts to bring cutting-edge inventions to life. His collaborative efforts have led to groundbreaking innovations with real-world applications.

Conclusion: Gregory N Stephanopoulos stands as a beacon of innovation in the field of biotechnology and chemical engineering, with a remarkable track record of patents and inventions that have shaped the industry. His dedication to sustainable solutions and collaborative spirit continue to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.